Flamel Technologies S.A. (FLML) 13.00 $FLML
Flamel Technologies to Report Third Quarter of Fiscal Year 2014 Results
Marketwired - Tue Oct 21, 8:07AM CDT
Flamel Technologies (NASDAQ: FLML) will release financial results for the third quarter of fiscal year 2014 on Friday, October 31, 2014, before the market open. A conference call to discuss these results has been scheduled for Friday, October 31st at 10:00 a.m. ET. A question and answer period will follow management's prepared remarks.
FLML: 13.00 (+0.33)
OTC Daily Alert Stock Watch - Flamel Technologies SA, (NASDAQ: FLML)
WorldStockWire - Sun Oct 19, 12:00AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
FLML: 13.00 (+0.33)
Uptrend Call Working As Flamel Technologies Stock Rises 17.0% (FLML)
Comtex SmarTrend(R) - Thu Oct 02, 11:06AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 4 months, Flamel Technologies has returned 16.98% as of today's recent price of $14.12.
FLML: 13.00 (+0.33)
Flamel Technologies Announces Positive Results of First-in-Man Clinical Trial With LiquiTime(R) Ibuprofen
Marketwire - Mon Sep 29, 8:15AM CDT
Flamel Technologies (NASDAQ: FLML) today announced the results of a First-in-Man (FIM) clinical study in healthy volunteers using its proprietary LiquiTime(R) drug delivery platform applied to ibuprofen, a broadly used medication for pain. LiquiTime is designed to provide a controlled, extended release of oral liquids principally for pediatric and geriatric patients.
FLML: 13.00 (+0.33)
Flamel Technologies Up 22.5% Since SmarTrend Uptrend Call (FLML)
Comtex SmarTrend(R) - Thu Sep 25, 9:44AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 4 months, Flamel Technologies has returned 22.53% as of today's recent price of $14.79.
FLML: 13.00 (+0.33)
The Best Biotech Stock for Your Growth Portfolio
Motley Fool Staff - Motley Fool - Thu Sep 25, 7:45AM CDT
For those willing to endure the inevitable price roller coaster, there's tremendous opportunity in hyper-growth biotech stocks. But you have to pick the best stocks if you're going to generate market-beating returns. So we asked each of our analysts...
FLML: 13.00 (+0.33), GILD: 106.67 (+4.46), CELG: 94.97 (+2.97)
Flamel Technologies Has Returned 18.1% Since SmarTrend Recommendation (FLML)
Comtex SmarTrend(R) - Thu Sep 18, 9:19AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 3 months, Flamel Technologies has returned 18.14% as of today's recent price of $14.26.
FLML: 13.00 (+0.33)
Flamel Technologies reports resignation of Gregg Stetsko as VP of its Research and Development
M2 - Thu Sep 11, 7:47AM CDT
Drug delivery company Flamel Technologies SA (NASDAQ:FLML) on Thursday disclosed the departure of Gregg Stetsko as vice president of its Research and Development to pursue other interests.
FLML: 13.00 (+0.33)
Flamel Technologies Announces Plan to Appoint New VP of R&D
Marketwire - Thu Sep 11, 6:00AM CDT
Flamel Technologies S.A. (NASDAQ: FLML) today announced that Gregg Stetsko, the Vice President of Research and Development at Flamel, has left the Company to pursue other interests. Mr. Stetsko joined Flamel approximately 18 months ago.
FLML: 13.00 (+0.33)
Flamel Technologies Up 18.3% Since SmarTrend Uptrend Call (FLML)
Comtex SmarTrend(R) - Wed Sep 10, 5:01PM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 3 months, Flamel Technologies has returned 18.31% as of today's recent price of $14.28.
FLML: 13.00 (+0.33)
22.0% Return Seen to Date on SmarTrend Flamel Technologies Call (FLML)
Comtex SmarTrend(R) - Wed Aug 27, 9:45AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 3 months, Flamel Technologies has returned 22.04% as of today's recent price of $14.73.
FLML: 13.00 (+0.33)
Flamel Technologies SA (FLML) in Focus: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 8:32AM CDT
Flamel Technologies SA (FLML) was a big mover last session, as the company saw its shares rise more than 8% on the day.
ENDP: 63.73 (+2.29), FLML: 13.00 (+0.33), UTHR: 127.61 (+1.15), HPTX: 22.75 (+0.08)
Nasdaq stocks posting largest percentage increases
AP - Thu Aug 21, 5:08PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
CRMT: 43.71 (+0.74), FLML: 13.00 (+0.33), ALOT: 12.93 (+0.18), BONT: 9.75 (+0.34), HPJ: 6.47 (-0.22), RDEN: 17.22 (-0.05), GALT: 5.09 (+0.03), HGSH: 4.21 (+0.24), DGLY: 12.99 (-0.15)
Flamel Technologies Shares Up 20.1% Since SmarTrend's Buy Recommendation (FLML)
Comtex SmarTrend(R) - Wed Aug 20, 9:18AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 3 months, Flamel Technologies has returned 20.13% as of today's recent price of $14.50.
FLML: 13.00 (+0.33)
Flamel Technologies Shares Up 13.6% Since SmarTrend's Buy Recommendation (FLML)
Comtex SmarTrend(R) - Tue Aug 12, 4:56PM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 2 months, Flamel Technologies has returned 13.59% as of today's recent price of $13.71.
FLML: 13.00 (+0.33)
Flamel Technologies SA (FLML) Soars: Stock Rises 10.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 7:51AM CDT
Flamel Technologies SA (FLML) was a big mover last session, as its shares rose almost 11% on the day.
ENDP: 63.73 (+2.29), FLML: 13.00 (+0.33), SLXP: 140.55 (-1.44), ENTA: 41.83 (-4.76)
Flamel Notified of FDA Communication to Unapproved Manufacturers of Neostigmine Methylsulfate
Marketwire - Mon Aug 04, 6:00AM CDT
Flamel Technologies S.A. (NASDAQ: FLML) has received communication from the U.S. Food and Drug Administration (FDA) that all manufacturers of unapproved versions of neostigmine methylsulfate have been notified by the FDA to cease manufacturing of the unapproved product as of July 30, 2014. Current inventory in the channel of the unapproved product can continue to be sold. Flamel has not been provided with information on the inventory levels held by these manufacturers.
FLML: 13.00 (+0.33)
Flamel Technologies to Report Third Quarter of Fiscal Year 2014 Results
Marketwired - Tue Oct 21, 8:07AM CDT
Flamel Technologies (NASDAQ: FLML) will release financial results for the third quarter of fiscal year 2014 on Friday, October 31, 2014, before the market open. A conference call to discuss these results has been scheduled for Friday, October 31st at 10:00 a.m. ET. A question and answer period will follow management's prepared remarks.
FLML: 13.00 (+0.33)
OTC Daily Alert Stock Watch - Flamel Technologies SA, (NASDAQ: FLML)
WorldStockWire - Sun Oct 19, 12:00AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
FLML: 13.00 (+0.33)
Uptrend Call Working As Flamel Technologies Stock Rises 17.0% (FLML)
Comtex SmarTrend(R) - Thu Oct 02, 11:06AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 4 months, Flamel Technologies has returned 16.98% as of today's recent price of $14.12.
FLML: 13.00 (+0.33)
Flamel Technologies Announces Positive Results of First-in-Man Clinical Trial With LiquiTime(R) Ibuprofen
Marketwire - Mon Sep 29, 8:15AM CDT
Flamel Technologies (NASDAQ: FLML) today announced the results of a First-in-Man (FIM) clinical study in healthy volunteers using its proprietary LiquiTime(R) drug delivery platform applied to ibuprofen, a broadly used medication for pain. LiquiTime is designed to provide a controlled, extended release of oral liquids principally for pediatric and geriatric patients.
FLML: 13.00 (+0.33)
Flamel Technologies Up 22.5% Since SmarTrend Uptrend Call (FLML)
Comtex SmarTrend(R) - Thu Sep 25, 9:44AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 4 months, Flamel Technologies has returned 22.53% as of today's recent price of $14.79.
FLML: 13.00 (+0.33)
The Best Biotech Stock for Your Growth Portfolio
Motley Fool Staff - Motley Fool - Thu Sep 25, 7:45AM CDT
For those willing to endure the inevitable price roller coaster, there's tremendous opportunity in hyper-growth biotech stocks. But you have to pick the best stocks if you're going to generate market-beating returns. So we asked each of our analysts...
FLML: 13.00 (+0.33), GILD: 106.67 (+4.46), CELG: 94.97 (+2.97)
Flamel Technologies Has Returned 18.1% Since SmarTrend Recommendation (FLML)
Comtex SmarTrend(R) - Thu Sep 18, 9:19AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 3 months, Flamel Technologies has returned 18.14% as of today's recent price of $14.26.
FLML: 13.00 (+0.33)
Flamel Technologies reports resignation of Gregg Stetsko as VP of its Research and Development
M2 - Thu Sep 11, 7:47AM CDT
Drug delivery company Flamel Technologies SA (NASDAQ:FLML) on Thursday disclosed the departure of Gregg Stetsko as vice president of its Research and Development to pursue other interests.
FLML: 13.00 (+0.33)
Flamel Technologies Announces Plan to Appoint New VP of R&D
Marketwire - Thu Sep 11, 6:00AM CDT
Flamel Technologies S.A. (NASDAQ: FLML) today announced that Gregg Stetsko, the Vice President of Research and Development at Flamel, has left the Company to pursue other interests. Mr. Stetsko joined Flamel approximately 18 months ago.
FLML: 13.00 (+0.33)
Flamel Technologies Up 18.3% Since SmarTrend Uptrend Call (FLML)
Comtex SmarTrend(R) - Wed Sep 10, 5:01PM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 3 months, Flamel Technologies has returned 18.31% as of today's recent price of $14.28.
FLML: 13.00 (+0.33)
22.0% Return Seen to Date on SmarTrend Flamel Technologies Call (FLML)
Comtex SmarTrend(R) - Wed Aug 27, 9:45AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 3 months, Flamel Technologies has returned 22.04% as of today's recent price of $14.73.
FLML: 13.00 (+0.33)
Flamel Technologies SA (FLML) in Focus: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 8:32AM CDT
Flamel Technologies SA (FLML) was a big mover last session, as the company saw its shares rise more than 8% on the day.
ENDP: 63.73 (+2.29), FLML: 13.00 (+0.33), UTHR: 127.61 (+1.15), HPTX: 22.75 (+0.08)
Nasdaq stocks posting largest percentage increases
AP - Thu Aug 21, 5:08PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
CRMT: 43.71 (+0.74), FLML: 13.00 (+0.33), ALOT: 12.93 (+0.18), BONT: 9.75 (+0.34), HPJ: 6.47 (-0.22), RDEN: 17.22 (-0.05), GALT: 5.09 (+0.03), HGSH: 4.21 (+0.24), DGLY: 12.99 (-0.15)
Flamel Technologies Shares Up 20.1% Since SmarTrend's Buy Recommendation (FLML)
Comtex SmarTrend(R) - Wed Aug 20, 9:18AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 3 months, Flamel Technologies has returned 20.13% as of today's recent price of $14.50.
FLML: 13.00 (+0.33)
Flamel Technologies Shares Up 13.6% Since SmarTrend's Buy Recommendation (FLML)
Comtex SmarTrend(R) - Tue Aug 12, 4:56PM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 6th, 2014 at $12.07. In approximately 2 months, Flamel Technologies has returned 13.59% as of today's recent price of $13.71.
FLML: 13.00 (+0.33)
Flamel Technologies SA (FLML) Soars: Stock Rises 10.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 7:51AM CDT
Flamel Technologies SA (FLML) was a big mover last session, as its shares rose almost 11% on the day.
ENDP: 63.73 (+2.29), FLML: 13.00 (+0.33), SLXP: 140.55 (-1.44), ENTA: 41.83 (-4.76)
Flamel Notified of FDA Communication to Unapproved Manufacturers of Neostigmine Methylsulfate
Marketwire - Mon Aug 04, 6:00AM CDT
Flamel Technologies S.A. (NASDAQ: FLML) has received communication from the U.S. Food and Drug Administration (FDA) that all manufacturers of unapproved versions of neostigmine methylsulfate have been notified by the FDA to cease manufacturing of the unapproved product as of July 30, 2014. Current inventory in the channel of the unapproved product can continue to be sold. Flamel has not been provided with information on the inventory levels held by these manufacturers.
FLML: 13.00 (+0.33)
